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ABSTRACT
Purpose: The aim of this study was to conduct a histologic evaluation of irradiated calvarial 
defects in rats 4 weeks after applying fibroblast growth factor-2 (FGF-2) with hyaluronan or 
biphasic calcium phosphate (BCP) block in the presence or absence of adjunctive hyperbaric 
oxygen (HBO) therapy.
Methods: Twenty rats were divided into HBO and non-HBO (NHBO) groups, each of which 
was divided into FGF-2 and BCP-block subgroups according to the grafted material. Localized 
radiation with a single 12-Gy dose was applied to the calvaria of rats to simulate radiotherapy. 
Four weeks after applying this radiation, 2 symmetrical circular defects with a diameter of 
6 mm were created in the parietal bones of each animal. The right-side defect was filled 
with the materials mentioned above and the left-side defect was not filled (as a control). All 
defects were covered with a resorbable barrier membrane. During 4 weeks of healing, 1 hour 
of HBO therapy was applied to the rats in the HBO groups 5 times a week. The rats were then 
killed, and the calvarial specimens were harvested for radiographic and histologic analyses.
Results: New bone formation was greatest in the FGF-2 subgroup, and improvement was not 
found in the BCP subgroup. HBO seemed to have a minimal effect on new bone formation. 
There was tendency for more angiogenesis in the HBO groups than the NHBO groups, but 
the group with HBO and FGF-2 did not show significantly better outcomes than the HBO-
only group or the NHBO group with FGF-2.
Conclusions: HBO exerted beneficial effects on angiogenesis in calvarial defects of 
irradiated rats over a 4-week healing period, but it appeared to have minimal effects on 
bone regeneration. FGF-2 seemed to enhance new bone formation and angiogenesis, but its 
efficacy appeared to be reduced when HBO was applied.
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INTRODUCTION
Radiotherapy after oral and maxillofacial cancer surgery often results in unwanted 
complications, such as osteoradionecrosis due to delayed bone healing associated with 
damage to osteoprogenitor cells and reduced neovascularization [1,2]. For example, a 
previous study found that the bone healing capacity decreased by 70.9% during a 4-week 
healing period after irradiation at bony sites prepared for dental implants in rabbit tibiae 
[3]. Impaired bone healing, as manifested by woven bone, immature bone marrow, and 
decreased bone mineral density, has also been reported in irradiated calvarial defects in 
rats [4]. Furthermore, the bone healing capacity decreases markedly in patients who receive 
radiotherapy for oral and maxillofacial cancers, which makes the rehabilitation procedure 
after cancer surgery more challenging [3].
Hyperbaric oxygen (HBO) therapy is regarded a possible adjunctive therapy for the 
management of irradiated bones whose healing or regenerative capacity decreases due to 
hypocellularity, hypovascularity, and hypoxia [5]. HBO therapy involves the inhalation of air 
that contains high amounts of oxygen to permit its systemic diffusion and delivery [6]. This 
therapy is usually performed in a chamber with 100% oxygen at an absolute atmospheric 
pressure between 2.0 and 2.5 atmospheres absolute (ATA). The volume of oxygen combined 
with hemoglobin in the blood is generally approximately 20%, but the volume of oxygen 
dissolved in the plasma increases with pressure [6]. The partial pressure of oxygen is 
normally 5–15 mmHg in irradiated tissues, and increases to 20–35 mmHg after HBO therapy 
[7]. Inhalation of oxygen at >1 ATA promotes the production of reactive oxygen species, 
which act as signaling molecules for various growth factors, cytokines, and hormones [8]. 
HBO-mediated oxidative stress stimulates the differentiation of circulating stem/progenitor 
cells and growth of new blood vessels by local endothelial cells [8]. Despite the effectiveness 
of HBO therapy in irradiated bones, its effects remain controversial. In animal studies, HBO 
therapy has been found to promote bone formation in normal bone and angiogenesis in 
irradiated bone [9,10]. However, other studies have argued that there is limited evidence to 
support any benefits of this therapy [11,12]. A randomized, placebo-controlled trial showed 
that HBO therapy was ineffective for treating mandibular radionecrosis [13]. Several side 
effects, such as reversible myopia and barotrauma, have also been reported [14].
Synthetic bone substitute materials are occasionally used for bone regeneration. Biphasic 
calcium phosphate (BCP), a type of synthetic bone substitute, is composed of hydroxyapatite 
and β-tricalcium phosphate. Previous studies have produced favorable results with BCP [15,16]. 
However, BCP lacks osteoinductive capacity, which is one of the drawbacks of using the currently 
available synthetic bone substitutes. Various attempts have recently been made to enhance the 
osteogenic potential of these synthetic bone substitutes. One method involves coating BCP 
with peptides such as bone morphogenetic protein, oligopeptide, or epigallocatechin-3-gallate, 
which can produce favorable results [17-19]. Another drawback of BCP bone substitute is that it 
is available in a particulate form, which prevents it from being properly maintained in defects 
that lack bony walls. A new type of BCP block has been fabricated using collagen to prevent the 
dissipation of BCP particles. This BCP block has excellent formability and can fit into the defects 
more easily; however, the added collagen might delay bone formation because it first needs to be 
resorbed before space becomes available for the new bone to form [20,21].
Growth factors have significant effects on osteoblast behavior and have thus been widely 
used for bone regeneration. Fibroblast growth factor-2 (FGF-2) is an effective angiogenic 
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and osteogenic growth factor [22]. It has been shown to induce angiogenesis and new bone 
formation in calvarial defects in rats and is considered to contribute to wound healing by 
stimulating the proliferation of mesenchymal cells [22]. It is effective both in normal and 
in irradiated bone [23]. Hyaluronan (HA), which is used as a carrier for FGF-2, is present 
throughout the body in the extracellular matrix as a naturally occurring biodegradable polymer 
responsible for the structural properties of tissues [24]. In a previous study, a viscous gel 
composed of FGF-2 and HA was introduced via injection into fractured bones as a novel 
treatment [25]. A single administration of this formulated gel in the fibulae of baboons with 
an experimentally created bilateral 1-mm gap defect accelerated fracture healing, providing 
evidence for increased callus formation and physical solidity relative to the untreated sites [25].
In light of the abovementioned findings, the aim of this study was to histologically evaluate 
irradiated rat calvarial defects at 4 weeks after applying FGF-2 or BCP block, with or without 
adjunctive HBO therapy.
MATERIALS AND METHODS
Experimental animals and materials
The study was carried out on 20 male Sprague-Dawley rats (body weight, 250–300 g, 4 weeks 
old) and approved by the Institutional Animal Care and Use committee of Yonsei Medical 
Center, Seoul, Korea (2012-0141-1). All experimental procedures were conducted according to 
the guidelines for animal experiments of Yonsei University, College of Dentistry.
One of the graft materials was a gel containing 0.07% FGF-2 (Genoss, Suwon, Korea) with 
2% HA (Genoss), and the other was BCP block (OsteonTM II collagen®, Genoss) composed of 
synthetic bone graft and bovine type I collagen. The BCP block was cut to the dimensions of 
the defect, with a diameter of 6 mm and a height of 1.5 mm. A resorbable barrier membrane 
(HA collagen membrane®, Genoss) was used bilaterally to prevent the defect from collapsing.
The rats were divided into HBO and non-HBO (NHBO) groups, which were each further 
divided into 2 subgroups: 1) FGF-2 with HA and 2) BCP block. Localized radiation with a 
single 12-Gy dose was applied to each rat calvarium. Four weeks after applying the radiation, 
2 symmetrical circular defects with a diameter of 6 mm were created in the parietal bones of 
each animal. The right-side defect was filled with FGF-2 and HA or BCP block, and the left-
side defect was not filled (as a control). The study groups can be summarized as follows:
HBO groups:
FGF-2 with HA (HBO-FGF-2 group; n=5)
BCP block (HBO-BCP group; n=5)
Control (HBO-control group; n=10)
NHBO groups:
FGF-2 with HA (NHBO-FGF-2 group; n=5)
BCP block (NHBO-BCP group; n=5)
Control (NHBO-control group; n=10)
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Protocol for animal irradiation
General anesthesia was induced with an intraperitoneal injection of an anesthetic cocktail 
composed of xylazine (Rompun, Bayer Korea, Seoul, Korea) and zolazepam (Zoletil 50, 
Virbac Laboratories, Carros, France). Rats were immobilized using a customized fixation 
device. Radiation fields were verified using an external beam simulator (Nucletron, 
Veenendaal, Netherlands). They received localized radiation with a single 12-Gy dose to the 
calvaria. The irradiation protocol for the calvaria of the rats was as follows: The sedated rat 
was placed in the fixation device to keep the animal in a prone and head-first position, with 
the head immobilized. Using a 2-dimensional simulator (Simulix Evolution, Nucletron), the 
position of the calvarium in the irradiation field was verified, and the treatment center was 
marked. The rat and fixation device were transferred to a 6-MV medical linear accelerator 
(Elekta Synergy, Elekta Oncology Systems, Stockholm, Sweden) that is commonly used for 
treatment in humans. A 0.5-cm tissue-equivalent bolus was placed on top of the rat's head to 
ensure electronic equilibrium. Using a field size of 2 cm×2 cm, a radiation dose of 12 Gy was 
delivered in a single application to the calvarium of each rat in 2 parallel-opposed, equally-
weighted lateral fields.
Surgical procedure
Four weeks after radiation, the surgical procedures were conducted under general anesthesia 
induced by the intraperitoneal injection of an anesthetic mixture of xylazine and zolazepam. 
The surgical area was shaved, and the skin was washed with 70% ethanol. An intraperitoneal 
injection of 0.9 mL of lidocaine (1:100,000 epinephrine, Yuhan, Seoul, Korea) was administered 
to control bleeding and provide additional anesthesia. A 20-mm-long midline incision 
was made in the scalp along the sagittal suture and the flaps were reflected laterally. Two 
symmetrical circular (6 mm in diameter) transosseous bone defects were then created in both 
parietal bones with a surgical trephine bur under saline irrigation. The midsagittal suture was 
not included in the bone defect to avoid damaging the dura mater. The left-side experimental 
defects were kept empty as a control, and the right-side defects were filled with FGF-2 and HA 
or BCP block. Resorbable membrane (HA collagen membrane®, Genoss) was applied with the 
aim of minimizing how much the defect collapsed. The skin flaps were repositioned and sutured 
with nonresorbable suture material. After 10 days, the sutures were removed.
All rats were given free access to food pellets and tap water while they were housed and cared 
for in the animal experimental laboratory of Yonsei University, College of Dentistry, Seoul, 
South Korea. The animals were killed after 4 weeks of healing by transcardial perfusion with 
4% paraformaldehyde under general anesthesia. The skin was removed from the calvarium 
and the calvarial specimens were harvested for histologic, histometric, and micro-computed 
tomography (CT) analysis. The tissue samples were fixed in 10% formalin for 24 hours and 
then decalcified by soaking in formic acid–hydrochloric acid for another 24 hours. They were 
then embedded in paraffin, with 5-μm-thick sections cut in the transverse plane and stained 
with hematoxylin and eosin (H&E). The histologic examination was performed with the aid 
of a light microscope.
Procedure for hyperbaric oxygen therapy
During 4 weeks of healing after graft surgery, the rats in the HBO groups were placed in a 
hyperbaric chamber and exposed to 100% oxygen at 2.4 ATA for 1 hour per day 5 times a 
week [26-28]. During this period, the animals in the NHBO groups were left in their usual 
housing. The HBO therapy began the day after surgery in a mono-place chamber designed for 
experimentation.
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Radiographic analysis: micro-CT
Block sections, including the augmented bony defect and the surrounding bone, were 
resected and fixed in 10% neutral-buffered formalin for 10 days. Radiographic images were 
then obtained using micro-CT (1076, SkyScan, Aartselaar, Belgium) at a resolution of 35 μm 
(achieved using 100 kV and 100 μA). OnDemand3D software (Cybermed, Seoul, Korea) was 
used to reconstruct the area of interest.
Histologic analysis
All specimens were decalcified with 10% EDTA at 4°C for 1 month. The decalcified specimens 
were first embedded in paraffin wax, and then a series of 5-μm-thick sections was prepared. 
The sections were stained with H&E and then observed with the aid of an optical microscope 
(BX51, Olympus, Tokyo, Japan). The area and length of new bone were measured with an image 
analysis system (Tomoro Scope Eye, Techsan Digital Imaging, Seoul, Korea) after taking images 
with a digital camera (OlympusBX50, Olympus) at magnifications of ×12.5 and ×50.
Histometric analysis
Images of histologic sections were captured with a digital camera (BX50, Olympus) at original 
magnifications of ×12.5 and ×50. Those images were saved on a computer. Histometric 
analysis was performed with the aid of image analysis software (version 3.6, Tomoro Scope 
Eye, Techsan Digital Imaging). The most central section was used to assess defect closure 
(width) and the percentage of bone formation (Figure 1A).
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Figure 1. Method of measuring new bone area (A) and length (B) (hematoxylin and eosin).
Immunohistological analysis
Microvessels were identified using immunohistochemical staining with monoclonal 
antibodies against endothelial cell adhesion molecule-1 (sc-1506-R, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). The sections were incubated for 30 minutes with 
horseradish peroxidase-labeled antirabbit immunoglobulin antibody (Dako, Glostrup, 
Denmark) after incubation with the primary antibodies. The sections were then incubated 
at room temperature for a further 20 minutes after rinsing in Tris-buffered saline, and then 
stained with diaminobenzidine (DAB) for 15 minutes. An optical microscope was used to 
evaluate the distribution and localization of stained endothelial cells in the defects. An 
overview image of the specimens was obtained at a magnification of ×200. DAB staining was 
evaluated on both defect sides within a 1-mm-wide strip (Figures 1B and 2).
Statistical analysis
Statistical analyses were performed using SPSS (version 18.0, SPSS, Chicago, IL, USA). The 
data are presented as mean values±standard deviation. To determine whether statistically 
significant differences existed among the 3 groups, the Kruskal-Wallis test was used. The 
cutoff for statistical significance was set at P<0.05. Three sets of pairs were compared using 
the Mann-Whitney U test with the Bonferroni correction. P values <0.017 were considered to 
statistical significance for these comparisons.
RESULTS
Radiographic analysis
Partial defect closure was found in all groups, and remnants of collagen membrane 
were found in all defects (Figure 3A-F). The bone substitute was well maintained in the 
BCP groups (Figure 3B and E). New bone formation in the BCP groups could not be 
differentiated from BCP particles on micro-CT. The amount of new bone formation around 
the defect margin was greater in the FGF-2 groups (Figure 3C and F) than in the control 
group (Figure 3A and D). The effect of HBO on new bone formation could not be evaluated 
using micro-CT data.
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50 µm
Figure 2. Method of counting blood vessels (diaminobenzidine) – arrowheads.
Histologic analysis
After the 4-week healing period, complete defect closure was not observed in any of the 
calvarial defects. However, there was no sign of inflammation or infection in any of the groups. 
A limited amount of new bone formation was observed in the control groups, but only around 
the defect margins. The dimensions of the defect decreased vertically in the control groups 
because no graft material had been applied (Figures 4A, 4D, 5A, and 5D). The dimensions of 
the defect were well maintained in the BCP groups. New bone formation was found around 
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Figure 3. Micro-computed tomography images. (A) NHBO-control group, (B) NHBO-BCP group, (C) NHBO-FGF-2 
group, (D) HBO-control group, (E) HBO-BCP group, (F) HBO-FGF-2 group. 
NHBO: without adjunctive hyperbaric oxygen treatment, BCP: biphasic calcium phosphate, FGF-2: fibroblast 
growth factor-2, HBO: adjunctive hyperbaric oxygen treatment.
A B C
D E F
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Figure 4. Histological images (hematoxylin and eosin). (A) NHBO-control group, (B) HBO-control group, (C) NHBO-BCP group, (D) HBO-BCP group, (E) NHBO-
FGF-2 group, (F) HBO-FGF-2 group. 
NHBO: without adjunctive hyperbaric oxygen treatment, HBO: adjunctive hyperbaric oxygen treatment, BCP: biphasic calcium phosphate, FGF-2: fibroblast 
growth factor-2.
the defect margins and BCP particles (Figures 4B, 4E, 5B, and 5E). New bone was found beside 
or under the defect margin. The dimensions of the defect also decreased in the FGF-2 groups. 
New bone formation was found around the defect margins (Figures 4C, 4F, 5C, and 5F). New 
bone isolated from the defect margin was also found. The amount of new bone formation 
around the defect margin was greater in the BCP groups than in the control groups.
Histometric analysis
New bone area
In the HBO group, significant differences were found among all subgroups (P=0.011). In 
particular, a statistically significant difference was found between the BCP and control 
groups (P=0.001). The results of the NHBO group were similar to those of the HBO group. 
However, no significant difference was found among subgroups (P=0.450). In the HBO and 
NHBO groups, new bone area was larger in the FGF-2 with HA subgroups than in the other 
subgroups. The presence of BCP block had an adverse effect on new bone area, while HBO 
appeared to have a minimal effect on new bone area (Table 1).
New bone length
In the HBO and NHBO groups, new bone length was also larger in the FGF-2 with HA 
subgroups than in the other subgroups. There was a statistically significant difference among 
the subgroups within the NHBO group (P=0.020). The P value for the difference between the 
BCP and control subgroups in the NHBO group was close to significant (P=0.019). Similar to 
new bone area, BCP block seemed to have an adverse effect on new bone length, while HBO 
had a minimal effect (Table 1).
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Figure 5. Histological images (hematoxylin and eosin). (A) NHBO-control group, (B) HBO-control group, (C) NHBO-BCP group, (D) HBO-BCP group, (E) NHBO-
FGF-2 group, (F) HBO-FGF-2 group. 
NHBO: without adjunctive hyperbaric oxygen treatment, HBO: adjunctive hyperbaric oxygen treatment, BCP: biphasic calcium phosphate, FGF-2: fibroblast 
growth factor-2.
Immunohistological analysis
In the HBO group, significant differences were found among the 3 subgroups (P=0.048). 
The P value for differences among the subgroups in the NHBO group was close to significant 
(P=0.051). A statistically significant difference was observed between the HBO-BCP subgroup 
and the NHBO-BCP subgroup (P=0.016). In general, more angiogenesis was found in the 
HBO groups than in the NHBO groups. However, when FGF-2 with HA was applied together 
with HBO therapy, angiogenesis was not improved relative to HBO alone or the NHBO group 
with FGF-2 and HA (Table 1).
DISCUSSION
In this study, FGF-2 with HA was used for the treatment of irradiated calvarial defects in rats 
because this combination was considered to facilitate both angiogenesis and osteogenesis. 
A previous study found that FGF-2 contributed to wound healing by stimulating the 
proliferation of mesenchymal cells and inducing angiogenesis and new bone formation in 
rat calvarial defects [22]. Another study showed that FGF-2 increased new bone formation 
in periodontal defects [23]. In this study, rats administered FGF-2 tended to show more 
new bone and blood vessel formation than the rats in the control groups. Moreover, new 
bone isolated from the defect margin formed in the FGF-2-administered rats. These results 
suggest that FGF-2 has the potential to induce new bone formation, although they did not 
show statistical significance. This most likely occurred because the healing period of 4 weeks 
was very short for determining differences in bone formation in irradiated calvarial defects. 
Further studies should be performed to investigate defects under the same conditions for a 
longer healing period.
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Table 1. Data of histometric and immunohistological analyses
Group New bone area (mm2) New bone length (mm) Blood vessel count (No.)
HBO
HBO-FGF-2 (n=5) 0.36±0.26 0.93±0.26 153.2±50.8
HBO-BCP (n=5) 0.17±0.04 0.58±0.15 234.0±41.1
HBO-control (n=10) 0.30±0.06 0.84±0.30 177.3±49.8
P value (FGF-2 vs. BCP vs. control) 0.011a) 0.068 0.048a)
P value (FGF-2 vs. control) 0.594 0.513 0.310
P value (BCP vs. control) 0.001b) 0.055 0.055
P value (FGF-2 vs. BCP) 0.056 0.056 0.032
P value (FGF-2 vs. FGF-2 in NHBO) 0.548 0.690 0.548
P value (BCP vs. BCP in NHBO) 1.000 0.548 0.016c)
NHBO
NHBO-FGF-2 (n=5) 0.34±0.09 1.00±0.34 163.2±43.0
NHBO-BCP (n=5) 0.17±0.11 0.51±0.18 161.8±28.1
NHBO-control (n=10) 0.29±0.12 0.81±0.19 122.3±27.9
P value (FGF-2 vs. BCP vs. control) 0.450 0.020a) 0.051
P value (FGF-2 vs. control) 0.440 0.206 0.099
P value (BCP vs. control) 0.099 0.019 0.028
P value (FGF-2 vs. BCP) 0.056 0.032 1.000
Values are presented as mean±standard deviation.
HBO: adjunctive hyperbaric oxygen treatment, FGF-2: fibroblast growth factor-2, BCP: biphasic calcium 
phosphate, NHBO: without adjunctive hyperbaric oxygen treatment.
a)Statistically significant difference (P<0.05) (Kruskal-Wallis test); b)Statistically significant difference (P<0.017, 
an adjusted significance level using Bonferroni correction); c)Statistically significant difference compared to the 
corresponding parameter in the HBO group (P<0.05).
Most reconstructions after resective surgery and radiotherapy are performed on bony defects 
that do not have bony walls. This clinical situation prevents the bone substitute from being 
properly maintained in the defect. BCP block, which comprises BCP particles and collagen, 
can be considered as an ideal substitute because the collagen is resorbed after the BCP 
particles, and new bone is formed in the space left thereafter. Therefore, new bone formation 
takes longer when using a BCP block than when using particulate BCP. The healing capacity 
of the irradiated bone in this study was lower than that observed in previous studies [23]. 
It seems that 4 weeks was not long enough for the irradiated bony defects to heal. Further 
studies should be performed to investigate the effect of BCP blocks over a longer healing 
time. In this study, the increased vascularity found in the BCP block groups can be attributed 
to collagen resorption because more blood vessels were observed around the bone substitute 
than around the defect margin. It is not certain whether this healing process would continue 
until new bone formation around the bone substitute. The smaller new bone area and 
length in the BCP block groups relative to the FGF-2 groups can also be attributed to delayed 
new bone formation when using a BCP block. However, different results are expected with 
increasing healing time (e.g., 8 weeks).
Previous studies have shown that HBO therapy induced greater new bone formation [29-31], 
whereas other studies have provided limited evidence for this finding [11,12]. In this study, 
HBO therapy did not exert any beneficial effect on new bone formation. However, the results 
could have been different if the healing time had been longer than 4 weeks. A previous study 
found favorable effects of HBO therapy on new bone formation in healing time frames of 6 and 
12 weeks [29]. Moreover, different results may be obtained when using different frequencies 
and durations of HBO therapy. For example, a previous study, in which HBO therapy was 
administered for 90 minutes per day 5 times a week for 4 weeks, suggested that HBO therapy 
had favorable effects on new bone formation [30]. Future studies should therefore are needed 
for evaluating the effects of other HBO therapy protocols. Increased angiogenesis was found 
in the HBO groups in the present study. While it is unclear whether this increased vascularity 
would favorably affect new bone formation, previous findings suggest that increased vascularity 
is associated with faster healing and more new bone formation [29-31].
There was a tendency for less bone formation when FGF-2 with HA was applied in 
combination with HBO therapy (i.e., the HBO-FGF-2 group) relative to using FGF-2 with HA 
without HBO. There was also less angiogenesis in the HBO-FGF-2 group than in the FGF-2 
with HA group (i.e., NHBO-FGF-2) or HBO therapy alone group (i.e., NHBO-control). This 
result is in accordance with that of a previous study [32]. The previous study also showed that 
FGF-2 was more effective than HBO therapy in improving bone growth after radiation, and 
that HBO therapy did not provide any additional beneficial effect to FGF-2 therapy. It was also 
explained that both modalities exert their effects via similar pathways. The data obtained in 
our study, together with the findings of previous studies, suggest that applying materials or 
modalities that exert similar effects simultaneously cannot be recommended. Future studies 
should consider a longer healing time, different protocols of HBO therapy, and different 
types of BCP, compared with this study.
Within the limitations of this study, our results suggest that HBO exerted beneficial effects 
on angiogenesis, but minimal effects on bone regeneration, in an irradiated rat model. FGF-2 
with HA enhanced bone generation and angiogenesis, but its efficacy was reduced when HBO 
was also applied. Using BCP block did not have any beneficial effect on bone regeneration.
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